Researchers have found a substitute for insulin to help treat diabetes orally, replacing painful pricks. Over 10 years, Erik Helmerhorst, professor at Curtin University, and colleagues looked at three million compounds on pharmaceutical databases to try to emulate the molecular map of insulin. They found one, and are developing it to 'take the needle out of diabetes'. "Our innovation is the development of a new chemical entity, a small drug molecule we have discovered and developed, that can be taken orally as a tablet to replace insulin per se," said Helmerhorst. The research has the ability to revolutionise the treatment of diabetes, which is a growing problem worldwide. Helmerhorst said there was a niche market for their drug molecule to target Type 2 diabetics to help delay the onset of insulin dependency, according to a Curtin statement. He said 95 percent of diabetics have Type 2 diabetes; they last year spent some $10 billion on insulin. "The reality is that nearly one-third of Type 2 diabetics will end up needing insulin therapy at some stage," he said. According to the scientist, the insulin substitute would appeal to people who were averse to taking insulin via injections or by pumps. Helmerhorst outlined his team's quest at the Univation 2011 conference in Perth Nov 2-3.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor